[Hanyu Pharmaceutical: Net profit is expected to increase by 503%-531% year-on-year in the first three quarters of 2026] On October 12, Hanyu Pharmaceutical (300199.SZ) announced that the net profit attributable to shareholders of listed companies in the first three quarters of 2026 is expected to be 430 million yuan-450 million yuan, a year-on-year increase of 502.65%-530.68%. The change in performance was mainly due to the company's continued expansion of its API business during the reporting period, which resulted in both revenue and profit growth. Xiaocai Note: The company’s Q3 net profit is expected to be 193 million to 213 million, and Q2 net profit is 109 million. Based on this calculation, Q3 net profit is expected to increase by 77% to 95% month-on-month.